It was observed that increased expression of VPAC1 receptors is associated with colon, breast, lung, thyroid, and prostate cancers, whereas only a few cancers, like leiomyomas and gastrointestinal stromal tumors, showed overexpression of VPAC2 during cancer progression. The gene discussed is VIPR1; the disease is leiomyoma.